India pharma production hit by propane shortage; vitamin, hormone supply at risk

The pharma sector is currently seeing recommendations for top stocks, but this propane shortage introduces a significant operational risk. This supply chain bottleneck could overshadow positive sentiment from recent stock picks.

• •India’s pharmaceutical industry faces medicine shortages due to a propane gas crunch.
• •Several manufacturing units are partially or fully shutting operations.
• •Production of key drugs including paracetamol, vitamins, and hormones is disrupted.
• •Risk flag: Prolonged propane shortage could lead to significant revenue loss for pharma companies.
• •Risk flag: Increased input costs if alternative energy sources are more expensive.